Provided by Tiger Fintech (Singapore) Pte. Ltd.

Outlook Therapeutics, Inc.

1.55
-0.0200-1.27%
Post-market: 1.52-0.0300-1.94%16:36 EDT
Volume:229.10K
Turnover:359.45K
Market Cap:50.56M
PE:-0.71
High:1.62
Open:1.61
Low:1.52
Close:1.57
Loading ...
May 31, 2022

Major Issues Report

8-K - Current report
May 13, 2022

Major Issues Report

8-K - Current report
May 13, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 22, 2022

Major Issues Report

8-K - Current report
Apr 22, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Apr 01, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Mar 31, 2022

Major Issues Report

8-K - Current report
Mar 25, 2022

Major Issues Report

8-K - Current report
Feb 16, 2022

Delisting

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
Feb 15, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Feb 14, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 01, 2022

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Dec 23, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Dec 23, 2021

Major Issues Report

8-K - Current report
Dec 22, 2021

Major Issues Report

8-K - Current report
Dec 01, 2021

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Nov 29, 2021

Major Issues Report

8-K - Current report
Nov 24, 2021

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Nov 23, 2021

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses